This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Biodistribution and Dosimetry of 18F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies
- Dose-Response Relationship in Differentiated Thyroid Cancer Patients Undergoing Radioiodine Treatment Assessed by Means of 124I PET/CT
- Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib
- Advances in Immuno-Positron Emission Tomography: Antibodies for Molecular Imaging in Oncology
- Bone Marrow Dosimetry Using 124I-PET
- 124I-huA33 Antibody Uptake Is Driven by A33 Antigen Concentration in Tissues from Colorectal Cancer Patients Imaged by Immuno-PET
- Dosimetry and thyroid cancer: the individual dosage of radioiodine
- Image-Quality Assessment for Several Positron Emitters Using the NEMA NU 4-2008 Standards in the Siemens Inveon Small-Animal PET Scanner
- Prediction of Absorbed Dose to Normal Organs in Thyroid Cancer Patients Treated with 131I by Use of 124I PET and 3-Dimensional Internal Dosimetry Software
- Radioimaging of Light Chain Amyloid with a Fibril-Reactive Monoclonal Antibody
- Acquisition Settings for PET of 124I Administered Simultaneously with Therapeutic Amounts of 131I
- The Promise of Immuno-PET in Radioimmunotherapy
- 124I-Labeled Engineered Anti-CEA Minibodies and Diabodies Allow High-Contrast, Antigen-Specific Small-Animal PET Imaging of Xenografts in Athymic Mice
- Immuno-PET of Human Colon Xenograft- Bearing BALB/c Nude Mice Using 124I-CDR-Grafted Humanized A33 Monoclonal Antibody
- Monitoring of Herpes Simplex Virus Thymidine Kinase Enzyme Activity Using Positron Emission Tomography